NASH
1 / 1
Liver Disease
Tackling Liver Disease with a Multimodal Cyclophilin Inhibitor
Robert Foster, Pharm.D., Ph.D.
Hepion Pharmaceuticals
PAO-06-022-CL-01Jun 02, 2022
Clinical Trials
Lipocine Announces Completion of Enrollment in LPCN 1144 Liver Imaging Study in Subjects At-Risk for NASH
Lipocine Inc.
PR-M11-18-NI-022Nov 07, 2018
1 / 1